sorafenib has been researched along with Cushing Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abouzied, Mel-D; Aklabi, S; Duaiji, N; Hammami, MM; Mutairi, G; Qattan, N; Sous, MW | 1 |
1 other study(ies) available for sorafenib and Cushing Syndrome
Article | Year |
---|---|
Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentr
Topics: Adult; Antineoplastic Agents; Aortic Aneurysm; Aortic Dissection; Carcinoma, Medullary; Cushing Syndrome; Diabetes Insipidus; Fatal Outcome; Humans; Hydrocortisone; Intussusception; Jejunal Diseases; Male; Niacinamide; Paraneoplastic Polyneuropathy; Phenylurea Compounds; Primary Dysautonomias; Sorafenib; Thyroid Neoplasms | 2015 |